Thirteen months after Illumina Inc. and Grail Inc. merged, prior to regulatory approval, the deal has taken a turn for the worse. The prognosis looked better following an administrative law judge’s ruling Sept. 1 against the U.S. Federal Trade Commission’s lawsuit seeking to block the transaction, but the European Commission (EC) issued a decision Sept. 6 prohibiting the deal based on the likelihood that a merger would stifle innovation and limit choices in the early cancer detection liquid biopsy market. Read More
Carbon Medtech (Shenzhen) Co. Ltd. reported that it has raised “tens of millions of yuan” from its pre-A+ round financing. This financing was jointly led by Jinding Capital and Shenzhen Small & Medium Enterprises Credit Financing Guarantee Group Co. Ltd. Read More
Massachusetts Institute of Technology (MIT) engineers in collaboration with South Korean cosmetic giant Amorepacific Corp. have created a chip-free, wireless electronic “skin” for sensing and transmitting vital medical signs minus larger, clunkier chips or batteries in most smartphones. MIT postdoc Jun Min Suh explained any change to the skin’s conditions, such as an accelerated heart rate, affect the sensor’s mechanical vibrations, generating an electrical signal that automatically transmits medial data to the consumer. Read More
Researchers from ESPCI Paris (Paris University for Industrial Physics and Chemistry), are working on a novel functional neuroimaging technique for measuring whole-brain activity dynamically at the microscopic level. Read More
Collagen is the most abundant protein in the human body, which would seem to make it an unlikely source for an immunotherapy target. But it is where researchers from Immatics Biotechnologies GmbH and the University of Pennsylvania have found a target that was expressed on stromal cells in a number of different solid tumors, but very rare in normal tissues. Read More
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advanced Illumination, Arcensus, Avance, C3, Curavit, Curvebeam, Dannam Valley, Exaktera, Freenome, Insight Medical, Ixlayer, Laurypath, Microm Microtech, Nanovibronix, Neolight, PHC Holdings, Pixcell, Quantumdx, Ra Medical Systems, S2 Genomics, Sansure, Tri-anim Health Services, Straxcorp. Read More
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Boston Scientific, Magnus Medical, Syntheticmr. Read More
